PuraPharm Corporation Limited
Research PuraPharm Corporation Limited (1498.HK) on Bullrun: market cap HKD 128.95M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1498.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 128.95M
- Financial periodFY2025
- RevenueHKD 336.11M
- Revenue growth-12.0%
- Net income-HKD 35.22M
- Free cash flowHKD 25.69M
- Gross margin53.6%
Valuation Snapshot
latest market cap is HKD 128.95M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 336.11M | -HKD 35.22M | HKD 25.69M | 53.6% | n/a | HKD 16.17M | HKD 351.14M | HKD 130.48M |
| FY2024 | HKD 382.09M | -HKD 35.44M | HKD 87.60M | 53.7% | -0.09 | HKD 12.79M | HKD 363.76M | HKD 111.20M |
| FY2023 | HKD 406.86M | -HKD 106.08M | HKD 57.95M | 53.2% | -0.27 | HKD 20.13M | HKD 424.77M | HKD 153.24M |
| FY2022 | HKD 448.07M | -HKD 120.21M | HKD 64.95M | 58.6% | -0.3 | HKD 75.83M | HKD 503.16M | HKD 258.29M |
| FY2021 | n/a | n/a | n/a | n/a | -0.31 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 128.95M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About PuraPharm Corporation Limited
PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PuraPharm Corporation Limited's market cap?
PuraPharm Corporation Limited's market capitalization is HKD 128.95M.
What does PuraPharm Corporation Limited do?
PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names.